Abbott
Scott Leinenweber has extensive experience in the healthcare and pharmaceuticals sectors, currently serving as Senior Vice President and Head of Licensing, Acquisitions, and Abbott Ventures at Abbott since July 2004. Leinenweber has held several leadership roles within Abbott, including Vice President of Investor Relations and General Manager of Global Marketing for Renal Pharmaceuticals. Additionally, Leinenweber has a background in marketing and sales for various pharmaceutical divisions. Outside of Abbott, Leinenweber served as a Non-Executive Board Member at Allergy Therapeutics from November 2018 to December 2022. Leinenweber holds an MBA in Business Administration and Management from Marquette University and a BBA in Finance from the University of Wisconsin Oshkosh.
Abbott
372 followers
Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry. Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.